Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

Trial ID or NCT#



not recruiting iconNOT RECRUITING


The purpose of this study is to measure the levels of serum proteins and other biomarkers in cervical cancer patients. We believe that some of these markers may be useful in selecting patients for specific types of cancer therapies. These markers may also help to predict response to therapy, relapse after therapy, and survival after therapy.

Official Title

Tissue and Plasma Biomarkers of Lymph Node Involvement in Cervical Cancer

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Patients must have a known or suspected cervical cancer. - Age >=18 years. - Patients must have no other active cancer at the time of diagnosis. - Patients must have no history of a hysterectomy. - Patients must be able to give informed consent. - Patients must be willing to undergo a biopsy of the cervical tumor to provide tissue for the study. - Patients must have completed a standard-of-care FDG-PET/CT prior to initiation of therapy, for assessment of lymph nodes.
Exclusion Criteria:
  1. - Pregnant women


Elizabeth Kidd
Elizabeth Kidd
Radiation oncologist
Associate Professor of Radiation Oncology (Radiation Therapy)
Nelson Teng
Jonathan S. Berek, MD, MMSc
Jonathan S. Berek, MD, MMSc
Gynecologic oncologist
Laurie Kraus Lacob Professor

Contact us to find out if this trial is right for you.


Dylann Fujimoto